These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28152317)

  • 1. Candida albicans morphology: still in focus.
    Jacobsen ID; Hube B
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):327-330. PubMed ID: 28152317
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
    Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
    Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purpurin suppresses Candida albicans biofilm formation and hyphal development.
    Tsang PW; Bandara HM; Fong WP
    PLoS One; 2012; 7(11):e50866. PubMed ID: 23226409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of loureirin A against Candida albicans biofilms.
    Lin MY; Yuan ZL; Hu DD; Hu GH; Zhang RL; Zhong H; Yan L; Jiang YY; Su J; Wang Y
    Chin J Nat Med; 2019 Aug; 17(8):616-623. PubMed ID: 31472899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by
    Manoharan RK; Lee JH; Kim YG; Lee J
    Front Cell Infect Microbiol; 2017; 7():447. PubMed ID: 29085811
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis.
    Pannanusorn S; Ramírez-Zavala B; Lünsdorf H; Agerberth B; Morschhäuser J; Römling U
    Eukaryot Cell; 2014 Apr; 13(4):438-51. PubMed ID: 24297446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 7-benzyloxyindole and other halogenated indoles to inhibit Candida albicans biofilm and hyphal formation.
    Manoharan RK; Lee JH; Lee J
    Microb Biotechnol; 2018 Nov; 11(6):1060-1069. PubMed ID: 29656577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
    Chen S; Xia J; Li C; Zuo L; Wei X
    BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulators of commensal and pathogenic life-styles of an opportunistic fungus-Candida albicans.
    Rai LS; Wijlick LV; Bougnoux ME; Bachellier-Bassi S; d'Enfert C
    Yeast; 2021 Apr; 38(4):243-250. PubMed ID: 33533498
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ke CL; Liao YT; Lin CH
    Virulence; 2021 Dec; 12(1):281-297. PubMed ID: 33427576
    [No Abstract]   [Full Text] [Related]  

  • 11. Subunits of the vacuolar H+-ATPase complex, Vma4 and Vma10, are essential for virulence and represent potential drug targets in Candida albicans.
    Kim SW; Park YK; Joo YJ; Chun YJ; Hwang JY; Baek JH; Kim J
    Fungal Biol; 2019 Oct; 123(10):709-722. PubMed ID: 31542189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Candida albicans lifestyles: growth on surfaces.
    Kumamoto CA; Vinces MD
    Annu Rev Microbiol; 2005; 59():113-33. PubMed ID: 16153165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis.
    Rossoni RD; de Barros PP; de Alvarenga JA; Ribeiro FC; Velloso MDS; Fuchs BB; Mylonakis E; Jorge AOC; Junqueira JC
    Biofouling; 2018 Feb; 34(2):212-225. PubMed ID: 29380647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermaseptin-S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes.
    Belmadani A; Semlali A; Rouabhia M
    J Appl Microbiol; 2018 Jul; 125(1):72-83. PubMed ID: 29476689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular networks in the fungal pathogen Candida albicans.
    Hall RA; Cottier F; Mühlschlegel FA
    Adv Appl Microbiol; 2009; 67():191-212. PubMed ID: 19245940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of Candida albicans hyphae.
    Sudbery PE
    Nat Rev Microbiol; 2011 Aug; 9(10):737-48. PubMed ID: 21844880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase.
    MacAlpine J; Daniel-Ivad M; Liu Z; Yano J; Revie NM; Todd RT; Stogios PJ; Sanchez H; O'Meara TR; Tompkins TA; Savchenko A; Selmecki A; Veri AO; Andes DR; Fidel PL; Robbins N; Nodwell J; Whitesell L; Cowen LE
    Nat Commun; 2021 Oct; 12(1):6151. PubMed ID: 34686660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum potentiates the expression of genes associated with antifungal drug resistance in C. albicans biofilms on central venous catheters.
    Samaranayake LP; Anil S; Hashem M; Vellappally S; Cheung BP
    Mycopathologia; 2015 Apr; 179(3-4):195-204. PubMed ID: 25515243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messenger RNA transport in the opportunistic fungal pathogen Candida albicans.
    McBride AE
    Curr Genet; 2017 Dec; 63(6):989-995. PubMed ID: 28512683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.